Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06145841

Metagenomic Next-Generation Sequencing Guides Anti-Infection Strategies

Clinical Application of Metagenomic Next-Generation Sequencing-Guided Anti-Infection Strategies in AIDS Patients With Severe Pneumonia and/or Sepsis

Status
Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Guangzhou 8th People's Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to observe the effectiveness of clinical application in guiding anti-infection treatments in AIDS patients with severe pneumonia and/or sepsis using Metagenomic Next-Generation Sequencing-based technology in the real world

Detailed description

The study focuses on AIDS patients with severe pneumonia and/or sepsis, divided into groups based on whether metagenomic next-generation sequencing technology is used in the real world or not. The groups are the metagenomic next-generation sequencing group and the conventional pathogen detection group, with metagenomic sequencing samples derived from blood specimens. The study compares the pathogen detection rates and clinical diagnosis conformity rates of the aforementioned groups, as well as the efficiency of diagnosis in guiding clinical treatment.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPathogen metagenomic next-generation sequencingIn diagnosing patients with AIDS combined with severe pneumonia and/or sepsis, use pathogen metagenomics technology to detect peripheral blood specimens

Timeline

Start date
2023-10-23
Primary completion
2026-10-23
Completion
2027-10-23
First posted
2023-11-24
Last updated
2023-11-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06145841. Inclusion in this directory is not an endorsement.